首页|基于网络药理学和分子对接技术对车前子治疗卵巢癌的药理机制研究

基于网络药理学和分子对接技术对车前子治疗卵巢癌的药理机制研究

扫码查看
目的 通过网络药理学、分子对接技术探究车前子治疗卵巢癌的主要活性成分和潜在作用机制.方法 利用中药药理学数据库与分析平台(TCMSP)和Swiss Target Prediction数据库获取车前子活性成分及潜在靶点;借助疗效药靶数据库(TTD)和基因疾病关联数据库(DisGeNET)检索卵巢癌相关疾病靶点,并将药物靶点和疾病靶点取交集绘制韦恩图;运用Cytoscape 3.9.1软件构建"药物-活性成分-疾病-靶点"网络,依据其节点度值筛选出核心成分;利用检索相互作用基因/蛋白质的搜索工具(STRING)数据库构建交集靶点的蛋白质相互作用网络,依据Cytoscape 3.9.1软件的"CytoNCA"插件筛选出核心靶点;借助注释、可视化和综合发现数据库(DAVID)对潜在治疗靶点进行富集分析;采用AutoDock Tools软件对部分活性成分与潜在靶点进行分子对接验证.结果 车前子的MOL000098(槲皮素)、MOL001663(3-表齐墩果酸)、MOL007819(8-羟基木犀草素)等成分可能通过关键靶点TP53、MAPK1、AKT1、ESR1、IL6作用于癌症通路、化学致癌-受体激活通路、内分泌抵抗通路、细胞衰老通路、蛋白聚糖相关的癌症通路、铂类药物耐药性等通路.分子对接结果显示,前2位核心成分与前5位核心靶点均有较好的结合能力.结论 车前子治疗卵巢癌可能与TP53、MAPK1、AKT1、ESR1、IL6等靶点及癌症通路、化学致癌-受体激活通路、内分泌抵抗通路、细胞衰老通路、蛋白聚糖相关的癌症通路、铂类药物耐药性通路等通路相关,其中槲皮素可能是其发挥作用的主要成分.
Study on the pharmacological mechanism of plantain seed in the treatment of ovarian cancer based on network pharmacology and molecular docking technology
Objective The main active components and potential mechanism of plantain seed(PS)in the treatment of ovarian cancer(OC)were explored by network pharmacology and molecular docking technology.Methods The traditional Chinese medicine systems pharmacology database and analysis platform(TCMSP)and Swiss target prediction database were used to obtain the active ingredients and potential targets of PS.OC-related disease targets were searched with the help of the therapeutic target database(TTD)and gene-disease associations database(DisGeNet).The intersection of drug targets and disease targets was used to draw a Venn diagram.Cytoscape 3.9.1 software was used to construct the"drug-active ingredient-disease-target"network,and the core components were screened out according to their node values.The protein interaction network of the intersecting targets was constructed by using the search tool for the retrieval of interacting genes/proteins(STRING)database,and the core targets were screened out according to the"CytoNCA"plugin of Cytoscape 3.9.1 software.Enrichment analysis of the potential therapeutic targets was conducted with the help of the database for annotation,visualization and integrated discovery(DAVID)database.AutoDock tools software was used to verify the molecular docking between some active ingredients and potential targets.Results MOL000098(quercetin),MOL001663(3-epidulic acid),MOL007819(8-hydroxyluteolin)and other components of PS might act on cancer pathways,chemocarcinogenic-receptor activation pathways,endocrine resistance pathways,cellular senescence pathways,proteoglycan-related cancer pathways,platinum drug resistance pathways and other pathways through key targets TP53,MAPK1,AKT1,ESR1,IL6.The molecular docking results showed that the first two core components and the top five core targets all had good binding ability.Conclusions The treatment of OC with PS may be related to targets like TP53,MAPK1,AKT1,ESR1,and IL6,and pathways like cancer pathways,chemocarnogenic-receptor activation pathways,endocrine resistance pathways,cellular senescence pathways,proteoglycan-related cancer pathways,and platinum drug resistance pathways,among which quercetin may be the main component for it to exert functions.

Plantain seedOvarian cancerNetwork pharmacologyMolecular dockingPharmacological mechanism

张玲、郭勇峰、罗添华、吴媛霞

展开 >

山西省儿童医院(山西省妇幼保健院)妇产科,太原 030012

山西省肿瘤医院妇科,太原 030012

山西省儿童医院儿外科,太原 030012

山西省儿童医院生殖医学中心,太原 030012

展开 >

车前子 卵巢癌 网络药理学 分子对接 药理机制

2024

中国性科学
中国性学会

中国性科学

CSTPCD
影响因子:1.394
ISSN:1672-1993
年,卷(期):2024.33(12)